BioCentury
ARTICLE | Clinical News

Anti-IgE (Hu-901): Began Phase I/II testing

July 19, 1999 7:00 AM UTC

Tanox Inc., Houston, Texas Product: Anti-IgE (Hu-901) Business: Autoimmune/Inflammation Therapeutic category: Antibody Target: IgE Description: Monoclonal antibody against IgE Indication: Treat severe...